1 / 28

A Closer Look: HIV in the Aging Population

A Closer Look: HIV in the Aging Population. HIV and Aging – Introduction. By 2015, >50% of all persons with HIV in the United States will be over 50 years of age 1 Many persons with HIV have survived to older ages and experience health-related challenges resulting from 2 HIV disease itself

maida
Download Presentation

A Closer Look: HIV in the Aging Population

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A Closer Look: HIV in the Aging Population

  2. HIV and Aging – Introduction • By 2015, >50% of all persons with HIV in the United States will be over 50 years of age1 • Many persons with HIV have survived to older ages and experience health-related challenges resulting from2 • HIV disease itself • Non-HIV comorbidities • Potential adverse effects of long-term ARV therapy • Of all persons with HIV in 2005, adults ≥50 years represented3 • 15% of all new diagnoses of HIV or AIDS • 24% of those living with HIV or AIDS • 35% of AIDS-related deaths • ART, antiretroviral therapy. • DHHS 2009. Medical management of older patients with HIV/AIDS. http://grants.nih.gov/grants/guide/pa-files/PA-09-017.html • Dolan L, Zack E. International Workshopon HIV and Aging. Rev Antiretrov Ther Infect Dis. 2010;9. Abstract P_19. • CDC 2008. HIV/AIDS among persons aged 50 and older. http://www.cdc.gov/hiv/topics/over50./resources/factsheets/over50.htm..

  3. HIV and Aging – Clinical Considerations • Patients >50 years are at greater risk for delayed testing than younger patients1 • Family practitioners are less likely to discuss risk factors for HIV/AIDS with older patients2 • Older HIV-infected individuals are less likely to seek out testing and medical care in the absence of symptoms3 • Symptomatic older HIV-infected individuals are more likely to misattribute HIV-related symptoms to the normal aging process or other illnesses3 1. Cuzin L, et al. Clin Infect Dis. 2007;45(5):654-657. 2. Skiest DJ, Keiser PO. Arch Fam Med. 1997;6(3):289-294. 3. Siegel K, et al. AIDS Care. 1999;11(5):525-535.

  4. HIV and the Aging Process • Aging and HIV associated with • Increased prevalence of comorbidities • Cognitive decline • Social isolation • Age affects body’s ability to metabolize and use drugs • Decreased efficiency in clearing drugs and poorer absorption result in irregular medication levels • Despite successful HIV therapy, long-term suppressed, chronically infected HIV persons have a shorter expected lifespan compared to uninfected individuals Vance DE. Am J Nurs. 2010;110:43-47.

  5. HIV and Aging: Shared Comorbidities

  6. Non-HIV Comorbidities Account for More Deaths in Persons With HIV Than HIV Itself D:A:D database (N = 33,347) 2192 deaths over 158,959 person-years Renal1% Lactic Acidosis/ Pancreatitis1% Other/ Unknown13% Bacterial Infection7% AIDS Related32% Non-natural9% CVD Related11% Liver Related14% Non-AIDS Cancers12% CVD, cardiovascular disease; D:A:D, Data Collection on Adverse Events of Anti-HIV Drugs. Adapted from Smith C et al. 16th CROI; February 8-11, 2009, Montreal, Canada. Abstract 145. http://www.natap.org/2009/CROI/croi_28.htm.

  7. HIV and Aging Influence the Pathogenesis of Non-AIDS Morbidity Genotoxicity and Mitochondrial Dysfunction T-Cell Regenerative Failure Chronic Inflammation Visceral Fat, Insulin Resistance, and Metabolic Syndrome Visceral Fat, Insulin Resistance, and Metabolic Syndrome HIV Aging • HIV infection and treatment can lead to lipodystrophy and lipoatrophy • Chronic inflammatory proteins influence HIV disease outcomes • Visceral obesity • Risk factor for age-associated complications • Source for chronic inflammatory proteins Deeks SG. Annu Rev Med. 2011;62:141-155.

  8. HIV and Aging Influence the Pathogenesis of Non-AIDS Morbidity (cont’d) Genotoxicity and Mitochondrial Dysfunction Genotoxicity and Mitochondrial Dysfunction T-Cell Regenerative Failure Chronic Inflammation Visceral Fat, Insulin Resistance, and Metabolic Syndrome HIV Aging • DNA damage and telomere shortening are strong determinants of cellular aging • Mitochondria dysfunction may contribute to cellular aging • Nucleoside analogs inhibit mitochondria synthesis • Release of mitochondrial DNA • Increase risk of oxidative damage Deeks SG. Annu Rev Med. 2011;62:141-155.

  9. HIV and Aging Influence the Pathogenesis of Non-AIDS Morbidity (cont’d) Genotoxicity and Mitochondrial Dysfunction T-Cell Regenerative Failure T-Cell Regenerative Failure Chronic Inflammation Visceral Fat, Insulin Resistance, and Metabolic Syndrome HIV Aging • HIV may indirectly affect the stem cell environment through inflammatory damage • HIV may directly infect hematopoietic stem cells; loss of stem cells can contribute to vascular dysfunction and cardiovascular disease • Reduced ability to regenerate T-cells • Progressive loss of hematopoietic progenitor cells  cellular senescence Deeks SG. Annu Rev Med. 2011;62:141-155.

  10. HIV and Aging Influence the Pathogenesis of Non-AIDS Morbidity (cont’d) Chronic Inflammation Genotoxicity and Mitochondrial Dysfunction T-Cell Regenerative Failure Chronic Inflammation Visceral Fat, Insulin Resistance, and Metabolic Syndrome HIV Aging • Microbial translocation • Immune dysregulation • Low-level HIV replication • Co-infection with CMV, herpes viruses, and other copathogens • Associated with morbidity and mortality • Persistent inflammation (eg, chronic viral infections) may result in compromised immune system Deeks SG. Annu Rev Med. 2011;62:141-155.

  11. Common Comorbidities in the Aging Population of People With HIV Neurocognitive Disorders Metabolic Disorders Bone Disorders Cardiovascular Disease Hepatic Dysfunction Cancer Renal Dysfunction

  12. Common Comorbidities in the Aging Population of People With HIV (cont’d) HAD, HIV-associated dementia. 1. Simone MJ et al. Geriatrics. 2008;63:6-12. 2. Wilkie FL et al. AIDS. 2003;33:S93–S105. 3. Bing EG et al. Arch Gen Psych. 2001;58:721-728. 4. Knobel H, Guelar A, Valldecillo G, et al. AIDS. 2001;15:1591-1593.

  13. Common Comorbidities in the Aging Population of People With HIV (cont’d) GFR, glomerular filtration rate. 1. DHHS 2011. Panel on antiretroviral guidelines for adults and adolescents. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. 2. Arnsten JH, et al. AIDS. 2007;21:617-623 3. Gallant JE, et al. JAMA. 2004;292:191-201 4. Guo X and Nzerue C. Clev Clin J Med. 2002;69:282-312 5. Schambelan M, Benson CA, Carr A, et al. JAIDS. 2002;31:257-275. 6. National Kidney Foundation. Am J Kidney Dis. 2002;39(Suppl 1):S76-S110. 7. Hruz PW. Am J Infect Dis. 2006;2:187-192.

  14. Distribution of Selected Comorbidities and Coinfections in a US Healthcare Claims Databasea aImpact National Benchmark Database. Nkhoma E et al. International Workshop on HIV and Aging. Rev Antiretrov Ther Infect Dis. 2010;9. Abstract O_16.

  15. HIV, Aging, and Immunosenescence

  16. Aging of the Immune System (Immunosenescence) Decreased production of IL-2 and IL-2 receptors1,2 Diminished T-cell function2 Shift from naïve to terminally differentiated, impaired T-cells3 Premature aging of immune system and eventual immunologic “exhaustion”3 • IL-2, interleukin-2. • Casau NC. Clin Infect Dis. 2005;41:855-863. • Simone MJ, Appelbaum J. Geriatrics. 2008;63:6-12. • Cao W et al. J Acquir Immune Defic Syndr. 2009;50:137-147.

  17. Similarities and Differences in T-Cell Compartment With Aging and HIV Infection Aging HIV Naïve CD4+ T-cells Naïve CD8+ T-cells CD28− CD8+T-cells CD31−CD4+ naïve T-cells CD31−CD4+naïve T-cells Stable proportion of T-cells Decreased Increased Reprinted with permission from Rickabaugh TM, Jamieson BD. Immunol Res. 2010;48:59-71.

  18. The Effects of Aging on HIV Treatment

  19. Benefits and Challenges of Treating HIV inAging Patients Untreated HIV increases risk of diseases associated with aging A SMART study subgroup analysis suggested that (re)initiation of ART for patients with CD4+ cell counts of >350 cells/mL is associated with a reduction in both opportunistic disease and serious non-AIDS events compared with patients (re)initiated with CD4+ cell counts of <250 cells/mL1 HIV treatment associated with greater risk of toxicity and drug–drug interactions secondary to2 Effects of normal aging HIV infection Comorbid conditions HIV treatment may be complicated by medications prescribed for non–HIV-associated conditions (eg, diabetes, hypertension, hyperlipidemia)2 Aging process may alter pharmacokinetics, in turn increasing potential for toxicity (eg, reduced cytochrome P450 metabolism)2 • Emery S, et al. J Infect Dis. 2008;197:1133-1144. • Simone MJ, Appelbaum J. Geriatrics. 2008;63:6-12.

  20. Older Patients With HIV and Treatment Adherence Studies show that older patients with HIV are more treatment adherent1,2 Retrospective case control study3 101 patients with HIV (mean age, 57 years) matched with 202 younger patients with HIV (mean age, 33 years) Older patients were less likely to interrupt ARV therapy than younger patients (11% vs 26%) • Wutoh AK et al. J Natl Med Assoc. 2001;93:243-250. • Silverberg MJ et al. Arch Intern Med. 2007;167:684-691. • Wellons MF et al. J Am Geriatr Soc. 2002;50:603-607.

  21. Effect of Age on Baseline CD4+ and CD8+ Cells CD4+/CD8+ ratios at baseline Patients < 50 years old = 0.33 Patients ≥ 50 years old = 0.27 CD4+/CD8+ ratios at 48 weeks Patients < 50 years old = +0.3 Patients ≥ 50 years old = +0.2 Shaefer M et al. International Workshop on HIV and Aging. Rev AntiretrovTher Infect Dis. 2010;9. Abstract O_05.

  22. Immunologic Response to HAART in Patients Aged ≥ 50 Years Increases in monthly CD4+ cell count significantly lower in patients aged ≥ 50 years • IQR, interquartile range. aP < 0.0001 for age < 50 years vs age ≥ 50 years in all subgroups. • Grabar S et al. AIDS. 2004;18:2029-2038. 2. Gras L et al. J Acquir Immune Defic Syndr. 2007;456:183-192.

  23. Clinical Progression of HIV in Patients Aged ≥ 50 Years • Prospective cohort study of 3015 treatment-naïve patients initiating ARV therapy • Higher risk of clinical progression but improved virologic response in patients ≥ 50 years old vs patients < 50 years old • At baseline, older patients more likely to have • – AIDS-defining event (P = 0.0001) • – Lower CD4+ cell count (P = 0.0002) • – Higher HIV-1 RNA level (P = 0.0001) Grabar S et al. AIDS. 2004;18:2029-2038.

  24. Achievement of HIV RNA Levels < 500 Copies/mL Within 1 Year of HAART Initiation • Patients ≥ 50 years had a 15% increased probability of achieving HIV-1 RNA levels < 500 copies/mL versus patients 18-39 years, even when adjusting for comorbidities • Adherence was the key factor in older patients achieving better viral response and similar long-term CD4+ cell counts Silverberg MJ et al. Arch Intern Med. 2007;167:684-691.

  25. Incidence of Laboratory Abnormalities After HAART Initiation by Age Group LDL, low-density lipoprotein; TC, total cholesterol LDL, low-density lipoprotein; TC, total cholesterol. Silverberg MJ. Arch Intern Med. 2007;167:684-691.

  26. Drugs Metabolized by Cytochrome P450 That May Interact With PIs and NNRTIs PIs, protease inhibitors; NNRTIs, non-nucleoside reverse transcription inhibitors; SSRI, selective serotonin reuptake inhibitor. Simone MJ, Appelbaum J. Geriatrics. 2008;63:6-12.

  27. Medication Use and Potential Drug Interactions in Older vs Younger Patients With HIV Tseng A et al. International Workshop on HIV and Aging. Rev Antiretroviral Ther Infect Dis. 2010;9. Abstract O_08.

  28. Summary • Incidence and prevalence of HIV/AIDS in older persons is increasing, a trend expected to continue • Relationship between HIV and aging is complex, synergistic, and influenced by numerous factors • Immunologic abnormalities present in HIV are consistent with certain changes to the immune system in elderly • Persons with HIV have a higher than expected risk for numerous conditions commonly associated with aging • Presence of comorbidities in older patients with HIV has important implications for antiretroviral selection

More Related